SEC INSIDER TRANSACTIONS

GENERAC HOLDINGS INC. (GNRC) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

GNRC · GENERAC HOLDINGS INC.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 26 filings · fetched 2026-11-13T18:00:24Z

Recent reported activity

0purchase rows on this page

11sale rows on this page

75matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-09Filed 2026-11-10	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F2	M Exercise / conversionStock Option (Right to Buy) · Derivative	100D	0	Direct	Form 4 ↗0001437749-26-036155
2026-11-09Filed 2026-11-10	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	S Sale (market/private)Common Stock · Non-derivative	100D	190	Direct	Form 4 ↗0001437749-26-036155
2026-11-09Filed 2026-11-10	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	M Exercise / conversionCommon Stock · Non-derivative	100A	119.54	Direct	Form 4 ↗0001437749-26-036155
2026-11-05Filed 2026-11-06	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 References: F1	S Sale (market/private)Common Stock · Non-derivative	100D	182.01	Direct	Form 4 ↗0001437749-26-035598
2026-11-05Filed 2026-11-06	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 References: F1	S Sale (market/private)Common Stock · Non-derivative	200D	182.01	Direct	Form 4 ↗0001437749-26-035598
2026-11-03Filed 2026-11-04	Raabe Kyle AndrewOfficer · President, Home Power Gen. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F3	M Exercise / conversionStock Option (Right to Buy) · Derivative	212D	0	Direct	Form 4 ↗0001437749-26-034927
2026-11-03Filed 2026-11-04	Raabe Kyle AndrewOfficer · President, Home Power Gen. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	S Sale (market/private)Common Stock · Non-derivative	212D	210	Direct	Form 4 ↗0001437749-26-034927
2026-11-03Filed 2026-11-04	Raabe Kyle AndrewOfficer · President, Home Power Gen. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	M Exercise / conversionCommon Stock · Non-derivative	212A	102.415	Direct	Form 4 ↗0001437749-26-034927
2026-11-03Filed 2026-11-04	Raabe Kyle AndrewOfficer · President, Home Power Gen. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	386D	210	Direct	Form 4 ↗0001437749-26-034927
2026-11-02Filed 2026-11-03	Jagdfeld AaronDirector · Officer · Chief Executive Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 12-04-2025 References: F1	S Sale (market/private)Common Stock · Non-derivative	5,000D	200.61	Direct	Form 4 ↗0001437749-26-034651
2026-10-30Filed 2026-11-03	LAMPEREUR ANDREWDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	159A	197.3	Direct	Form 4 ↗0001437749-26-034653
2026-10-30Filed 2026-11-03	Morgan Bennett JDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	165A	197.3	Direct	Form 4 ↗0001437749-26-034657
2026-10-30Filed 2026-11-03	Zarcone Dominick PDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	A Award / grantCommon Stock · Non-derivative	127A	197.3	Direct	Form 4 ↗0001437749-26-034660
2026-10-30Filed 2026-11-02	Nguyen Nam TranDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	G GiftCommon Stock · Non-derivative	213D	0	Direct	Form 4 ↗0001437749-26-034458
2026-10-06Filed 2026-10-07	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F3	M Exercise / conversionStock Option (Right to Buy) · Derivative	150D	0	Direct	Form 4 ↗0001437749-26-032333
2026-10-06Filed 2026-10-07	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	S Sale (market/private)Common Stock · Non-derivative	150D	220	Direct	Form 4 ↗0001437749-26-032333
2026-10-06Filed 2026-10-07	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	M Exercise / conversionCommon Stock · Non-derivative	150A	119.54	Direct	Form 4 ↗0001437749-26-032333
2026-10-05Filed 2026-10-07	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F3	M Exercise / conversionStock Option (Right to Buy) · Derivative	100D	0	Direct	Form 4 ↗0001437749-26-032333
2026-10-05Filed 2026-10-07	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	100D	215.46	Direct	Form 4 ↗0001437749-26-032333
2026-10-05Filed 2026-10-07	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	M Exercise / conversionCommon Stock · Non-derivative	100A	119.54	Direct	Form 4 ↗0001437749-26-032333
2026-10-05Filed 2026-10-07	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	100D	215.46	Direct	Form 4 ↗0001437749-26-032333
2026-10-05Filed 2026-10-07	Taffe Norman POfficer · President Generac Home Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 03-06-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	200D	215.46	Direct	Form 4 ↗0001437749-26-032333
2026-10-02Filed 2026-10-06	Raabe Kyle AndrewOfficer · President, Home Power Gen. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F3	M Exercise / conversionStock Option (Right to Buy) · Derivative	213D	0	Direct	Form 4 ↗0001437749-26-032193
2026-10-02Filed 2026-10-06	Raabe Kyle AndrewOfficer · President, Home Power Gen. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	S Sale (market/private)Common Stock · Non-derivative	213D	212.57	Direct	Form 4 ↗0001437749-26-032193
2026-10-02Filed 2026-10-06	Raabe Kyle AndrewOfficer · President, Home Power Gen. Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Adoption date of referenced 10b5-1(c) plan is: 05-05-2026 F2 Multiple lots for the same price for this order have been combined. F3 Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. References: F1	M Exercise / conversionCommon Stock · Non-derivative	213A	102.415	Direct	Form 4 ↗0001437749-26-032193

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.